Company / Depreciation & Amortization
NEKTAR THERAPEUTICS Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$1.0M
FY2025
5-year range
$1.0M / $13.0M
FY2021-FY2025
Trend
-85.3%
vs FY2024
Sector context
#122 of 163
Health Care
What the data says
NEKTAR THERAPEUTICS's depreciation & amortization of $1M is lower than 75% of companies in the Health Care sector (FY2025). Depreciation & Amortization has fluctuated over the past 10 years, ranging from $1M in FY2025 to $13M in FY2018.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of -34.9%.
Improved from $13M to $1M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -56.2%
- 5-Year CAGR
- -34.9%
- 10-Year CAGR
- -
Sector benchmark
-99.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -34.9%, indicating a declining trend.
- In FY2025, depreciation & amortization decreased 85.3% year-over-year.
- Ranks #122 out of 163 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -11.97 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.0M | -85.3% |
| FY2024 | $7.0M | -46.2% |
| FY2023 | $13.0M | +6.6% |
| FY2022 | $12.2M | -6.2% |
| FY2021 | $13.0M | +47.7% |
| FY2020 | $8.8M | -30.2% |
| FY2019 | $12.6M | -4.5% |
| FY2018 | $13.2M | +4.8% |
| FY2017 | $12.6M | -2.5% |
| FY2016 | $12.9M | +13.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026